Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Migliore

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Intellectual and Developmental Disabilities|May 27, 2024
The State of Employment for People With IDD: Implications for Practice, Policy, and EquityJohn Butterworth, Jean E Winsor, Esther Kamau, et al.
Archives of Environmental & Occupational Health|October 31, 2007
Multiple chemical sensitivity syndrome in Sjögren's syndrome patients: casual association or related diseases?Alberto Migliore, Emanuele Bizzi, Umberto Massafra, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2016
The Challenge of Treating Early-Stage Rheumatoid Arthritis: The Contribution of Mixed Treatment Comparison to Choosing Appropriate Biologic AgentsAlberto Migliore, Emanuele Bizzi, Lea Petrella, et al.
Expert Opinion on Pharmacotherapy|June 22, 2016
An update on the up and coming therapies to treat osteoarthritis, a multifaceted diseaseJorge A Roman-Blas, Emanuele Bizzi, Raquel Largo, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 2, 2016
Costs associated with rheumatoid arthritis in Italy: past, present, and futureMaurizio Benucci, Veronica Rogai, Fabiola Atzeni, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 16, 2019
Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritisAlberto Migliore, Davide Integlia, Giuseppe Pompilio, et al.
Clinical Drug Investigation|November 13, 2014
Indirect comparison between subcutaneous biologic agents in ankylosing spondylitisAlberto Migliore, Emanuele Bizzi, Mauro Bernardi, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 8, 2010
Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanerceptAndrea Picchianti-Diamanti, Valentina Germano, Claudia Ferlito, et al.
International Journal of Molecular Sciences|July 13, 2024
Chondrotoxicity of Intra-Articular Injection Treatment: A Scoping ReviewCarmelo Pirri, Andrea Sorbino, Nicola Manocchio, et al.
Seminars in Arthritis and Rheumatism|August 4, 2018
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature reviewEmmanuel Maheu, Raveendhara R Bannuru, Gabriel Herrero-Beaumont, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Intellectual and Developmental Disabilities|May 27, 2024
The State of Employment for People With IDD: Implications for Practice, Policy, and EquityJohn Butterworth, Jean E Winsor, Esther Kamau, et al.
Archives of Environmental & Occupational Health|October 31, 2007
Multiple chemical sensitivity syndrome in Sjögren's syndrome patients: casual association or related diseases?Alberto Migliore, Emanuele Bizzi, Umberto Massafra, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2016
The Challenge of Treating Early-Stage Rheumatoid Arthritis: The Contribution of Mixed Treatment Comparison to Choosing Appropriate Biologic AgentsAlberto Migliore, Emanuele Bizzi, Lea Petrella, et al.
Expert Opinion on Pharmacotherapy|June 22, 2016
An update on the up and coming therapies to treat osteoarthritis, a multifaceted diseaseJorge A Roman-Blas, Emanuele Bizzi, Raquel Largo, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 2, 2016
Costs associated with rheumatoid arthritis in Italy: past, present, and futureMaurizio Benucci, Veronica Rogai, Fabiola Atzeni, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 16, 2019
Cost-effectiveness and budget impact analysis of viscosupplementation with hylan G-F 20 for knee and hip osteoarthritisAlberto Migliore, Davide Integlia, Giuseppe Pompilio, et al.
Clinical Drug Investigation|November 13, 2014
Indirect comparison between subcutaneous biologic agents in ankylosing spondylitisAlberto Migliore, Emanuele Bizzi, Mauro Bernardi, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 8, 2010
Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanerceptAndrea Picchianti-Diamanti, Valentina Germano, Claudia Ferlito, et al.
International Journal of Molecular Sciences|July 13, 2024
Chondrotoxicity of Intra-Articular Injection Treatment: A Scoping ReviewCarmelo Pirri, Andrea Sorbino, Nicola Manocchio, et al.
Seminars in Arthritis and Rheumatism|August 4, 2018
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature reviewEmmanuel Maheu, Raveendhara R Bannuru, Gabriel Herrero-Beaumont, et al.
Pageof 10